RESUMO
The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative diseases to incorporate antioxidant effects without losing affinity and selectivity at HDAC6. Structure-activity relationships led to compound 10b as a hybrid molecule showing pronounced and selective inhibition of HDAC6 (IC50 = 30.7 nM, > 25-fold selectivity over other subtypes). This compound shows comparable DPPH radical scavenging ability to ferulic acid, comparable ORAC value to melatonin and comparable Cu2+ chelating ability to EDTA. It also lacks neurotoxicity on HT-22 cells, exhibits a pronounced immunomodulatory effect, and is active in vivo showing significantly higher efficacy in an AD mouse model to prevent both Aß25-35-induced spatial working and long-term memory dysfunction at lower dose (0.3 mg/kg) compared to positive control HDAC6 inhibitor ACY1215 and an equimolar mixture of the three entities ACY1215, melatonin and ferulic acid, suggesting potentially disease-modifying properties.
Assuntos
Doença de Alzheimer/tratamento farmacológico , Ácidos Cumáricos/uso terapêutico , Desacetilase 6 de Histona/antagonistas & inibidores , Fatores Imunológicos/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Triptaminas/uso terapêutico , Doença de Alzheimer/enzimologia , Doença de Alzheimer/metabolismo , Animais , Domínio Catalítico , Linhagem Celular Transformada , Ácidos Cumáricos/síntese química , Ácidos Cumáricos/metabolismo , Desacetilase 6 de Histona/química , Desacetilase 6 de Histona/metabolismo , Inibidores de Histona Desacetilases/síntese química , Inibidores de Histona Desacetilases/metabolismo , Inibidores de Histona Desacetilases/uso terapêutico , Fatores Imunológicos/síntese química , Fatores Imunológicos/metabolismo , Masculino , Melatonina/análogos & derivados , Melatonina/metabolismo , Melatonina/uso terapêutico , Camundongos , Simulação de Acoplamento Molecular , Fármacos Neuroprotetores/síntese química , Fármacos Neuroprotetores/metabolismo , Relação Estrutura-Atividade , Triptaminas/síntese química , Triptaminas/metabolismoRESUMO
KEY MESSAGE: WsWRKY1-mediated transcriptional modulation of Withania somnifera tryptophan decarboxylase gene (WsTDC) helps to regulate fruit-specific tryptamine generation for production of withanamides. Withania somnifera is a highly valued medicinal plant. Recent demonstration of novel indolyl metabolites called withanamides in its fruits (berries) prompted us to investigate its tryptophan decarboxylase (TDC), as tryptophan is invariably a precursor for indole moiety. TDC catalyzes conversion of tryptophan into tryptamine, and the catalytic reaction constitutes a committed metabolic step for synthesis of an array of indolyl metabolites. The TDC gene (WsTDC) was cloned from berries of the plant and expressed in E. coli. The recombinant enzyme was purified and characterized for its catalytic attributes. Catalytic and structural aspects of the enzyme indicated its regulatory/rate-limiting significance in generation of the indolyl metabolites. Novel tissue-wise and developmentally differential abundance of WsTDC transcripts reflected its preeminent role in withanamide biogenesis in the fruits. Transgenic lines overexpressing WsTDC gene showed accumulation of tryptamine at significantly higher levels, while lines silenced for WsTDC exhibited considerably depleted levels of tryptamine. Cloning and sequence analysis of promoter of WsTDC revealed the presence of W-box in it. Follow-up studies on isolation of WsWRKY1 transcription factor and its overexpression in W. somnifera revealed that WsTDC expression was substantially induced by WsWRKY1 resulting in overproduction of tryptamine. The study invokes a key role of TDC in regulating the indolyl secondary metabolites through enabling elevated flux/supply of tryptamine at multiple levels from gene expression to catalytic attributes overall coordinated by WsWRKY1. This is the first biochemical, molecular, structural, physiological and regulatory description of a fruit-functional TDC.
Assuntos
Descarboxilases de Aminoácido-L-Aromático/genética , Proteínas de Plantas/genética , Triptaminas/biossíntese , Withania/genética , Withania/metabolismo , Descarboxilases de Aminoácido-L-Aromático/química , Descarboxilases de Aminoácido-L-Aromático/metabolismo , Clonagem Molecular , Dissacarídeos/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Regulação da Expressão Gênica de Plantas , Indóis/metabolismo , Modelos Moleculares , Filogenia , Proteínas de Plantas/química , Proteínas de Plantas/metabolismo , Plantas Geneticamente Modificadas , Plantas Medicinais/genética , Plantas Medicinais/metabolismo , Regiões Promotoras Genéticas , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Triptaminas/metabolismoRESUMO
Migraine is a common disabling disorder that affects 36 million Americans. The clinical features of migraine are less typical in the people above age 60, making the diagnosis and treatment difficult in this group. In this review, we will discuss migraine-specific drugs and their use in populations about age 60 who suffer from migraine. This discussion will include an overview of traditional treatments for the acute and preventive treatment of migraine, and considerations for their use in patient populations above age 60. In addition, we will discuss newer agents that show a more promising safety profile.
Assuntos
Envelhecimento/efeitos dos fármacos , Transtornos de Enxaqueca/tratamento farmacológico , Manejo da Dor/métodos , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/metabolismo , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/efeitos adversos , Anti-Inflamatórios não Esteroides/metabolismo , Quimioterapia Combinada , Feminino , Humanos , Masculino , Transtornos de Enxaqueca/diagnóstico , Transtornos de Enxaqueca/metabolismo , Manejo da Dor/tendências , Agonistas do Receptor 5-HT1 de Serotonina/administração & dosagem , Agonistas do Receptor 5-HT1 de Serotonina/efeitos adversos , Agonistas do Receptor 5-HT1 de Serotonina/metabolismo , Triptaminas/administração & dosagem , Triptaminas/efeitos adversos , Triptaminas/metabolismoRESUMO
Characterization of the melatonin (MLT) biosynthesis pathway in plants is still limited. Additionally, a metabolomic analysis of MLT biosynthesis in plants is still a challenge due to analyte structural and chemical diversity, low analyte abundances, and plant matrix complexities. Herein, a sensitive liquid chromatography-mass spectrometry (LC-MS) method enabling the simultaneous determination of seven plant MLT biosynthetic metabolites was developed. In the proposed strategy, the targeted metabolites, which included tryptophan (Trp), tryptamine (TAM), 5-hydroxytryptophan (5HTP), serotonin (5HT), N-acetylserotonin (NAS), 5-methoxytryptamine (5MT), and MLT, were purified from plant extracts using a one-step dispersive solid-phase extraction (DSPE). The samples were then chemically labeled with dansyl chloride (DNS-Cl), followed by analysis using LC-MS. The limit of detection (LOD) values ranged from 0.03 to 1.36 pg/mL and presented a 22- to 469-fold decrease when compared to the unlabeled metabolites. Due to the high sensitivity of the proposed method, the consumption of plant materials was reduced to 10 mg FW. Ultimately, the established method was utilized to examine the distributions of MLT and its intermediates in rice shoots and roots with or without cadmium (Cd) stress. The results suggested that under normal condition, MLT may also be generated via a Trp/TAM/5HT/5MT/MLT path (Pathway II) in addition to the previously reported Trp/TAM/5HT/NAS/MLT path (Pathway I), although Pathway I was shown to be dominant. During Cd stress, MLT was also shown to be produced through these two pathways, with Pathway II shown to be dominant in rice shoots and roots.
Assuntos
Cromatografia Líquida/métodos , Espectrometria de Massas/métodos , Melatonina/metabolismo , 5-Hidroxitriptofano/metabolismo , 5-Metoxitriptamina/metabolismo , Serotonina/metabolismo , Triptaminas/metabolismo , Triptofano/metabolismoRESUMO
Transgenic mice used for Alzheimer's disease (AD) preclinical experiments do not recapitulate the human disease. In our models, the dietary tryptophan metabolite tryptamine produced by human gut microbiome induces tryptophanyl-tRNA synthetase (TrpRS) deficiency with consequent neurodegeneration in cells and mice. Dietary supplements, antibiotics and certain drugs increase tryptamine content in vivo. TrpRS catalyzes tryptophan attachment to tRNAtrp at initial step of protein biosynthesis. Tryptamine that easily crosses the blood-brain barrier induces vasculopathies, neurodegeneration and cell death via TrpRS competitive inhibition. TrpRS inhibitor tryptophanol produced by gut microbiome also induces neurodegeneration. TrpRS inhibition by tryptamine and its metabolites preventing tryptophan incorporation into proteins lead to protein biosynthesis impairment. Tryptophan, a least amino acid in food and proteins that cannot be synthesized by humans competes with frequent amino acids for the transport from blood to brain. Tryptophan is a vulnerable amino acid, which can be easily lost to protein biosynthesis. Some proteins marking neurodegenerative pathology, such as tau lack tryptophan. TrpRS exists in cytoplasmic (WARS) and mitochondrial (WARS2) forms. Pathogenic gene variants of both forms cause TrpRS deficiency with consequent intellectual and motor disabilities in humans. The diminished tryptophan-dependent protein biosynthesis in AD patients is a proof of our model-based disease concept.
Assuntos
Doença de Alzheimer/metabolismo , Bactérias/metabolismo , Encéfalo/metabolismo , Microbioma Gastrointestinal , Trato Gastrointestinal/microbiologia , Degeneração Neural , RNA de Transferência/metabolismo , Aminoacilação de RNA de Transferência , Doença de Alzheimer/microbiologia , Doença de Alzheimer/patologia , Animais , Encéfalo/patologia , Modelos Animais de Doenças , Interações Hospedeiro-Patógeno , Humanos , Camundongos , Fenótipo , Biossíntese de Proteínas , Triptaminas/metabolismo , Triptofano-tRNA Ligase/genética , Triptofano-tRNA Ligase/metabolismoRESUMO
Catharanthus roseus today occupies the central position in ongoing metabolic engineering efforts in medicinal plants. The entire multi-step biogenetic pathway of its very expensive anticancerous alkaloids vinblastine and vincristine is fairly very well dissected at biochemical and gene levels except the pathway steps leading to biosynthesis of monomeric alkaloid catharanthine and tabersonine. In order to enhance the plant-based productivity of these pharma molecules for the drug industry, cell and tissue cultures of C. roseus are being increasingly tested to provide their alternate production platforms. However, a rigid developmental regulation and involvement of different cell, tissues, and organelles in the synthesis of these alkaloids have restricted the utility of these cultures. Therefore, the present study was carried out with pushing the terpenoid indole alkaloid pathway metabolic flux towards dimeric alkaloids vinblastine and vincristine production by over-expressing the two upstream pathway genes tryptophan decarboxylase and strictosidine synthase at two different levels of cellular organization viz. callus and leaf tissues. The transformation experiments were carried out using Agrobacterium tumefaciens LBA1119 strain having tryptophan decarboxylase and strictosidine synthase gene cassette. The callus transformation reported a maximum of 0.027% dry wt vindoline and 0.053% dry wt catharanthine production, whereas, the transiently transformed leaves reported a maximum of 0.30% dry wt vindoline, 0.10% catharanthine, and 0.0027% dry wt vinblastine content.
Assuntos
Catharanthus/química , Engenharia Genética/métodos , Triptaminas/metabolismo , Alcaloides de Vinca/síntese química , Alcaloides de Vinca/químicaRESUMO
Rice bran (RB) is a major by-product of rice polishing and a rich source of bioactive compounds. Here, we investigated the anti-colitis effect of diet supplementation with fermented rice bran (FRB) in a murine model of ulcerative colitis. FRB was prepared by dual fermentation of RB using fungi and lactic acid bacteria. Colitis was induced in C57Bl/6N male mice (n = 8/group) by dextran sodium sulfate (DSS). Body weight change, disease activity index (DAI), histopathology score, tissue myeloperoxidase (MPO) activity, cytokine and chemokine transcript levels, and the production of short-chain fatty acids (SCFAs) and mucin in the colonic tissue were monitored. Based on histopathology scores, DSS induced severe mucosal inflammation, with an increased loss of crypts, and inflammatory cell infiltration in the control and RB groups, but not in the FRB group. MPO activity, thiobarbituric acid-reactive substance levels, and pro-inflammatory cytokine transcript (Tnf-α, Il-1ß, Il-6, and Il-17) levels were significantly higher in the control and RB groups than in the FRB group. Thus, dietary FRB attenuated intestinal inflammation owing to elevated SCFAs and tryptamine production, which might regulate tight junction barrier integrity and intestinal homeostasis. These results suggest that FRB could comprise an effective potential preventive agent for ulcerative colitis.
Assuntos
Colite Ulcerativa/tratamento farmacológico , Fibras na Dieta/farmacologia , Suplementos Nutricionais , Fermentação , Animais , Colite Ulcerativa/induzido quimicamente , Colo/metabolismo , Citocinas/genética , Citocinas/metabolismo , Sulfato de Dextrana , Modelos Animais de Doenças , Ácidos Graxos Voláteis/metabolismo , Manipulação de Alimentos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Peroxidase/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Junções Íntimas/metabolismo , Triptaminas/metabolismo , Triptofano/metabolismoRESUMO
It is well known that the isolation of monoamine oxidase (MAO) inhibitors from natural sources is an important strategy for drug development in the treatment of depression, Parkinson's disease and Alzheimer's disease. The present work describes developing a thin-layer chromatography (TLC) bioautographic method for detecting MAO inhibitors from plant extracts. The basic principle of the method is that the enzyme oxidises tryptamine into an aldehyde which in turn reacts with 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide to form a blue formazan which makes a blue-coloured background on the TLC plates. Inhibitors of MAO produced white spots on the background. The new TLC bioautographic method has several advantages such as lower consumption of the enzyme, shorter experimental time, more easily observed background of TLC plate and better reproducibility. The detection limits were 10 ng for several known MAO inhibitors.
Assuntos
Cromatografia em Camada Fina/métodos , Medicamentos de Ervas Chinesas/química , Liquidambar/química , Inibidores da Monoaminoxidase/análise , Plantas Medicinais/química , Animais , Frutas/química , Fígado/metabolismo , Masculino , Ratos , Ratos Wistar , Reprodutibilidade dos Testes , Sais de Tetrazólio , Tiazóis , Triptaminas/metabolismoRESUMO
The classic "enlightenment" experience is that of Siddhartha Gautama (a.k.a. Buddha) who fasted and meditated intensely for years but failed to attain his goal of "enlightenment." He gave up his fast, ate rice pudding, and immediately meditated again, whereupon he attained "enlightenment." The hypothesis is that this altered state was a symptom of refeeding after prolonged starvation resulting from the combination of monoamine oxidase (MAO) inhibition followed by tryptophan and carbohydrate intake. Intense fasting inhibited Gautama's MAO activity; eating rice pudding constituted an intake of dietary tryptophan with carbohydrates. Carbohydrates trigger insulin release, which increases unbound tryptophan while reducing levels of competing amino acids at the blood-brain barrier. These effects allow significant amounts of tryptophan into the brain, where it converts into serotonin. Without MAO, serotonin does not degrade, and methyl-transferases convert excess tryptophan and serotonin into endogenous psychoactive tryptamines. The endogenous serotonin and tryptamines cause altered mental states. The absence of psychoactive substances and the prolonged fasting gives this experience its perceived spiritual power. Subjects may have no option but to assume that their experiences were due to either divine intervention or to values and techniques that took many years of hard work to acquire. If validated, this mechanism implicates a specific effect of refeeding syndrome as the trigger for these altered states, and offers an approach to study this phenomenon in untrained subjects from within a scientific framework.
Assuntos
Comportamento Alimentar , Serotonina/metabolismo , Espiritualidade , Triptaminas/metabolismo , Idoso , Animais , HumanosRESUMO
One pathway leading to the bioactive auxin, indole-3-acetic acid (IAA), is known as the tryptamine pathway, which is suggested to proceed in the sequence: tryptophan (Trp), tryptamine, N-hydroxytryptamine, indole-3-acetaldoxime, indole-3-acetaldehyde (IAAld), IAA. Recently, this pathway has been characterized by the YUCCA genes in Arabidopsis (Arabidopsis thaliana) and their homologs in other species. YUCCA is thought to be responsible for the conversion of tryptamine to N-hydroxytryptamine. Here we complement the genetic findings with a compound-based approach in pea (Pisum sativum), detecting potential precursors by gas chromatography/tandem-mass spectrometry. In addition, we have synthesized deuterated forms of many of the intermediates involved, and have used them to quantify the endogenous compounds, and to investigate their metabolic fates. Trp, tryptamine, IAAld, indole-3-ethanol, and IAA were detected as endogenous constituents, whereas indole-3-acetaldoxime and one of its products, indole-3-acetonitrile, were not detected. Metabolism experiments indicated that the tryptamine pathway to IAA in pea roots proceeds in the sequence: Trp, tryptamine, IAAld, IAA, with indole-3-ethanol as a side-branch product of IAAld. N-hydroxytryptamine was not detected, but we cannot exclude that it is an intermediate between tryptamine and IAAld, nor can we rule out the possibility of a Trp-independent pathway operating in pea roots.
Assuntos
Ácidos Indolacéticos/metabolismo , Pisum sativum/metabolismo , Triptaminas/metabolismo , Isótopos de Carbono/metabolismo , Cromatografia Gasosa-Espectrometria de Massas , Ácidos Indolacéticos/isolamento & purificação , Pisum sativum/genética , Extratos Vegetais/análise , Raízes de Plantas/metabolismo , Espectrometria de Massas em Tandem , Triptaminas/isolamento & purificaçãoRESUMO
The enzyme strictosidine synthase (STR1) from the Indian medicinal plant Rauvolfia serpentina is of primary importance for the biosynthetic pathway of the indole alkaloid ajmaline. Moreover, STR1 initiates all biosynthetic pathways leading to the entire monoterpenoid indole alkaloid family representing an enormous structural variety of approximately 2000 compounds in higher plants. The crystal structures of STR1 in complex with its natural substrates tryptamine and secologanin provide structural understanding of the observed substrate preference and identify residues lining the active site surface that contact the substrates. STR1 catalyzes a Pictet-Spengler-type reaction and represents a novel six-bladed beta-propeller fold in plant proteins. Structure-based sequence alignment revealed a common repetitive sequence motif (three hydrophobic residues are followed by a small residue and a hydrophilic residue), indicating a possible evolutionary relationship between STR1 and several sequence-unrelated six-bladed beta-propeller structures. Structural analysis and site-directed mutagenesis experiments demonstrate the essential role of Glu-309 in catalysis. The data will aid in deciphering the details of the reaction mechanism of STR1 as well as other members of this enzyme family.
Assuntos
Carbono-Nitrogênio Liases/química , Carbono-Nitrogênio Liases/metabolismo , Rauwolfia/enzimologia , Sequência de Aminoácidos , Sítios de Ligação , Catálise , Sequência Conservada , Modelos Moleculares , Dados de Sequência Molecular , Proteínas de Plantas/química , Proteínas de Plantas/metabolismo , Conformação Proteica , Dobramento de Proteína , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Especificidade por Substrato , Triptaminas/metabolismoRESUMO
A growing body of evidence demonstrates the efficacy of Garcinia cambogia-derived natural (-)-hydroxycitric acid (HCA) in weight management by curbing appetite and inhibiting body fat biosynthesis. However, the exact mechanism of action of this novel phytopharmaceutical has yet to be fully understood. In a previous study, we showed that in the rat brain cortex a novel HCA extract (HCA-SX, Super CitriMax) increases the release/availability of radiolabeled 5-hydroxytryptamine or serotonin ([3H]-5-HT), a neurotransmitter implicated in the regulation of eating behavior and appetite control. The aim of the present study was 2-fold: (a) to determine the effect of HCA-SX on 5-HT uptake in rat brain cortex in vitro; and (b) to evaluate the safety of HCA-SX in vivo. Isolated rat brain cortex slices were incubated in oxygenated Krebs solution for 20 min and transferred to buffer solutions containing [3H]-5-HT for different time intervals. In some experiments, tissues were exposed to HCA-SX (10 microM - 1 mM) and the serotonin receptor reuptake inhibitors (SRRI) fluoxetine (100 microM) plus clomipramine (10 microM). Uptake of [3H]-5-HT was expressed as d.p.m./mg wet weight. A time-dependent uptake of [3H]-5-HT occurred in cortical slices reaching a maximum at 60 min. HCA-SX, and fluoxetine plus clomipramine inhibited the time-dependent uptake of [3H]-5-HT. At 90 min, HCA-SX (300 microM) caused a 20% decrease, whereas fluoxetine plus clomipramine inhibited [3H]-5-HT uptake by 30%. In safety studies, acute oral toxicity, acute dermal toxicity, primary dermal irritation and primary eye irritation, were conducted in animals using various doses of HCA-SX. Results indicate that the LD50 of HCA-SX is greater than 5,000 mg/kg when administered once orally via gastric intubation to fasted male and female Albino rats. No gross toxicological findings were observed under the experimental conditions. Taken together, these in vivo toxicological studies demonstrate that HCA-SX is a safe, natural supplement under the conditions it was tested. Furthermore, HCA-SX can inhibit [3H]-5-HT uptake (and also increase 5-HT availability) in isolated rat brain cortical slices in a manner similar to that of SRRIs, and thus may prove beneficial in controlling appetite, as well as treatment of depression, insomnia, migraine headaches and other serotonin-deficient conditions.
Assuntos
Depressores do Apetite/toxicidade , Citratos/toxicidade , Extratos Vegetais/toxicidade , Administração Cutânea , Administração Oral , Animais , Apetite/efeitos dos fármacos , Depressores do Apetite/administração & dosagem , Depressores do Apetite/farmacologia , Peso Corporal/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Citratos/administração & dosagem , Citratos/farmacologia , Derme/efeitos dos fármacos , Olho/efeitos dos fármacos , Comportamento Alimentar/efeitos dos fármacos , Feminino , Garcinia cambogia/química , Masculino , Extratos Vegetais/administração & dosagem , Extratos Vegetais/farmacologia , Plantas Medicinais , Ratos , Ratos Sprague-Dawley , Serotonina/metabolismo , Triptaminas/metabolismoRESUMO
A transgenic Saccharomyces cerevisiae was constructed containing the cDNAs coding for strictosidine synthase (STR) and strictosidine beta-glucosidase (SGD) from the medicinal plant Catharanthus roseus. Both enzymes are involved in the biosynthesis of terpenoid indole alkaloids. The yeast culture was found to express high levels of both enzymes. STR activity was found both inside the cells (13.2 nkatal/g fresh weight) and in the medium (up to 25 nkatal/l medium), whereas SGD activity was present only inside the yeast cells (2.5 mkatal/g fresh weight). Upon feeding of tryptamine and secologanin, this transgenic yeast culture produced high levels of strictosidine in the medium; levels up to 2 g/l were measured. Inside the yeast cells strictosidine was also detected, although in much lower amounts (0.2 mg/g cells). This was due to the low permeability of the cells towards the substrates, secologanin and tryptamine. However, the strictosidine present in the medium was completely hydrolyzed to cathenamine, after permeabilizing the yeast cells. Furthermore, transgenic S. cerevisiae was able to grow on an extract of Symphoricarpus albus berries serving as a source for secologanin and carbohydrates. Under these conditions, the addition of tryptamine was sufficient for the transgenic yeast culture to produce indole alkaloids. Our results show that transgenic yeast cultures are an interesting alternative for the production of plant alkaloids.
Assuntos
Frutas/metabolismo , Alcaloides Indólicos/metabolismo , Iridoides , Piranos/metabolismo , Saccharomyces cerevisiae/enzimologia , Transgenes , Triptaminas/metabolismo , Biotecnologia/métodos , Carbono-Nitrogênio Liases/genética , Carbono-Nitrogênio Liases/metabolismo , Meios de Cultura , Frutas/química , Engenharia Genética , Glucosidases/genética , Glucosidases/metabolismo , Glucosídeos Iridoides , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/crescimento & desenvolvimentoRESUMO
Copper amine oxidase from lentil seedlings was shown to be able to catalyze the oxidative deamination of the indoleamines tryptamine, 5-hydroxytryptamine, and 5-methoxytryptamine. These compounds showed saturation kinetics with Km values as normal substrates, but their oxidation led to irreversible loss of enzyme activity suggesting a covalent interaction with the enzyme, most probably through its cofactor 6-hydroxydopa (2,4,5-trihydroxyphenylalanine). These indoleamines acted as irreversible inhibitors of the enzyme only in the absence of oxygen but they brought about changes in the electronic spectra of the enzyme both in aerobiosis and in anaerobiosis. This study reports on the mechanism by which these compounds inhibit lentil amine oxidase which involves first the oxidation of indoleamines bound to 6-hydroxydopa followed by the formation of an irreversible covalent derivative. The same inhibitory mechanism could possibly lead to inactivation of mammalian amine oxidases involved in serotonin neurotransmitter metabolism in conditions of ischemia or hypoxia.
Assuntos
Amina Oxidase (contendo Cobre)/antagonistas & inibidores , Fabaceae/enzimologia , Plantas Medicinais , Triptaminas/metabolismo , Amina Oxidase (contendo Cobre)/metabolismo , Fluorescência , Oxirredução , Sementes/enzimologia , Triptaminas/farmacologiaRESUMO
Psychotria viridis and P. carthagenensis are often discussed in relation to the hallucinogenic beverage Ayahuasca, used for religious, medicinal and social purposes. The significance of including Psychotria species in this beverage has been understood on the basis of substantial amounts of tryptamine alkaloids detected on leaves of both P. viridis and P. carthagenensis. Nevertheless, there is a long lasting debate over the identification of which Psychotria species are actually traditionally employed. We here report that a P. carthagenensis leaf ethanol extract was found to be devoid of alkaloids. The extract significantly decreased mice body temperature (350 and 500 mg/kg). Toxicity assessment revealed that the extract induced sedation and slight ptoses (75% of animals treated with 1000 mg/kg). Lethality was not observed within 48 h. The data indicate that P. carthagenensis does have bioactive compound(s), possibly active at the central nervous system, but unlikely to be tryptamine alkaloids as in the case of P. viridis. Therefore, if P. carthagenensis is indeed used by ayahuasqueros, its chemical and pharmacological significance have yet to be elucidated.
Assuntos
Alucinógenos/farmacologia , Análise de Variância , Animais , Bebidas , Temperatura Corporal/efeitos dos fármacos , Sistema Nervoso Central/efeitos dos fármacos , Etanol/química , Alucinógenos/administração & dosagem , Alucinógenos/toxicidade , Hipnóticos e Sedativos/toxicidade , Masculino , Camundongos , Extratos Vegetais/metabolismo , Extratos Vegetais/farmacologia , Extratos Vegetais/toxicidade , Folhas de Planta/metabolismo , Intoxicação/mortalidade , Triptaminas/análise , Triptaminas/metabolismoRESUMO
The kinetics and distribution of [3H]tryptamine binding sites in human brain were investigated. Specific [3H]tryptamine binding in frontal cortex was of nanomolar affinity, reversible, saturable, and best fit to a single-site model. A heterogeneous distribution for this binding site was demonstrated, with the highest density observed in hippocampus, thalamus >> caudate nucleus, frontal cortex, pons, temporal cortex > globus pallidus/putamen, cerebellum. The similarities in kinetics and distribution of the [3H]tryptamine binding site in human and rat brain indicate that these two binding sites represent homologous structures. However, the present displacement studies using various ligands (indoleamines and other tryptophan metabolites, phenylethylamines, and miscellaneous drugs) and salts (Na+, K+, Ca2+, Mg2+, Cu2+) indicate stereospecific displacement as well as a rank-order potency profile that is different from that reported for the rat [3H]tryptamine binding site. This suggests the presence of distinct species-dependent [3H]tryptamine binding site subtypes. Taken together with the documented electrophysiological and behavioral evidence of tryptamine-mediated effects in the rat and the recent report of a significant loss of these binding sites in human portal systemic encephalopathy, as well as the present demonstration of an effect of guanine nucleotides on [3H]-tryptamine binding affinity, these findings suggest that these binding sites might be functional receptors. The implied role of tryptamine in neuropsychiatric disorders is supported by this demonstration of a receptor for [3H]-tryptamine in human brain.
Assuntos
Encéfalo/metabolismo , Receptores de Serotonina/metabolismo , Triptaminas/metabolismo , Animais , Lobo Frontal/efeitos dos fármacos , Lobo Frontal/metabolismo , Guanilil Imidodifosfato/farmacologia , Hipocampo/metabolismo , Humanos , Cinética , Ratos , Receptores de Serotonina/efeitos dos fármacos , Sulfatos/farmacologia , Tálamo/metabolismo , Distribuição Tecidual , TrítioRESUMO
Cruciferous plants are known to produce over a hundred different mustard oil glycosides, which are derived from methionine, phenylalanine, or tryptophan. In oil-producing crops like Brassica napus (canola), the presence of indole glucosinolates in seed protein meals has decreased meal palatability and has limited their value as animal feed. We have transformed canola plants with a gene that encodes tryptophan decarboxylase (TDC) in an attempt to redirect tryptophan into tryptamine rather than into indole glucosinolates. Transgenic plants that expressed this decarboxylase activity accumulated tryptamine while correspondingly lower levels of tryptophan-derived indole glucosinolates were produced in all plant parts compared with nontransformed controls. Of particular significance, the indole glucosinolate content of mature seeds from transgenic plants was only 3% of that found in nontransformed seeds. These results demonstrate how the creation of artificial metabolic sinks could divert metabolite flow and be used to remove these undesirable indole glucosinolates, thereby increasing the value of the oilseed meals, which are produced after extraction of oil from the seed.
Assuntos
Descarboxilases de Aminoácido-L-Aromático/metabolismo , Brassica/metabolismo , Ácidos Graxos Monoinsaturados/metabolismo , Glucosinolatos/metabolismo , Indóis/metabolismo , Triptofano/metabolismo , Descarboxilases de Aminoácido-L-Aromático/genética , Sequência de Bases , Brassica/genética , Brassica/crescimento & desenvolvimento , Clonagem Molecular , DNA , Ácidos Graxos Monoinsaturados/química , Dados de Sequência Molecular , Plantas Geneticamente Modificadas , Óleo de Brassica napus , Sementes/crescimento & desenvolvimento , Transformação Genética , Triptaminas/metabolismoRESUMO
1. The 5-hydroxytryptamine (5-HT) receptor binding selectivity profile of a novel, potent 5-HT1D receptor agonist, L-694,247 (2-[5-[3-(4-methylsulphonylamino)benzyl-1,2,4-oxadiazol-5-yl ]- 1H-indole-3-yl]ethylamine) was assessed and compared with that of the 5-HT1-like receptor agonist, sumatriptan. 2. L-694,247 had an affinity (pIC50) of 10.03 at the 5-HT1D binding site and 9.08 at the 5-HT1B binding site (sumatriptan: pIC50 values 8.22 and 5.94 respectively). L-694,247 retained good selectivity with respect to the 5-HT1A binding site (pIC50 = 8.64), the 5-HT1C binding site (6.42), the 5-HT2 binding site (6.50) and the 5-HT1E binding site (5.66). The pIC50 values for sumatriptan at these radioligand binding sites were 6.14, 5.0, < 5.0 and 5.64 respectively. Both L-694,247 and sumatriptan were essentially inactive at the 5-HT3 recognition site. 3. L-694,247, like sumatriptan, displayed a similar efficacy to 5-HT in inhibiting forskolin-stimulated adenylyl cyclase in guinea-pig substantia nigra although L-694,247 (pEC50 = 9.1) was more potent than sumatriptan (6.2) in this 5-HT1D receptor mediated functional response. L-694,247 (pEC50 = 9.4) was also more potent than sumatriptan (6.5) in a second 5-HT1D receptor mediated functional response, the inhibition of K(+)-evoked [3H]-5-HT release from guinea-pig frontal cortex slices. 4. The excellent agreement observed for L-694,247 between the 5-HTlD radioligand binding affinity and the functional potency confirm that the two functional models (the inhibition of forskolin-stimulated adenylyl cyclase in guinea-pig substantia nigra and the inhibition of K+-evoked [3H]-5-HT release from guinea-pig frontal cortex) do indeed reflect 5-HTID-mediated events.5. L-694,247 is a novel, highly potent 5-HTID/5-HTIB receptor ligand which should prove useful for the exploration of the physiological role of these receptors in animals.
Assuntos
Oxidiazóis/farmacologia , Agonistas do Receptor de Serotonina/farmacologia , Triptaminas/farmacologia , Adenilil Ciclases/metabolismo , Animais , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Colforsina/farmacologia , Lobo Frontal/efeitos dos fármacos , Lobo Frontal/metabolismo , Técnicas In Vitro , Oxidiazóis/metabolismo , Potássio/antagonistas & inibidores , Potássio/farmacologia , Ensaio Radioligante , Receptores de Serotonina/metabolismo , Serotonina/metabolismo , Agonistas do Receptor de Serotonina/metabolismo , Estimulação Química , Substância Negra/efeitos dos fármacos , Substância Negra/enzimologia , Suínos , Trítio , Triptaminas/metabolismoRESUMO
In Catharanthus roseus cell cultures the time courses of four enzyme activities, tryptophan decarboxylase (TDC), strictosidine synthase (SSS), geraniol-10-hydroxylase (G10H) and anthranilate synthase (AS), and alkaloid accumulation were compared under two different culture conditions (low-inoculum density and high-inoculum density on induction medium) and a control on growth medium. In growth medium a transient increase in TDC activity was first observed after which G10H reached its maximum activity; only tryptamine accumulated, no ajmalicine could be detected. Apparently, a concerted induction of enzyme activities is required for ajmalicine formation. Cells inoculated in induction medium showed such a concerted induction of AS, TDC and G10H activities. After 30 days the low-density culture had accumulated six times more ajmalicine (in mumoles/g) than the high-density culture. Thus, increase in biomass concentration (high-density cultures) did not enhance the total alkaloid production. The major differences observed in enzyme levels between high- and low-density cultures were in the AS and TDC activities, which were two to three times higher in the low-density culture, indicating that there is a positive correlation between ajmalicine formation and AS and TDC activities.
Assuntos
Anti-Inflamatórios não Esteroides/metabolismo , Antineoplásicos/metabolismo , Carbono-Nitrogênio Liases , Alcaloides de Triptamina e Secologanina , Ioimbina/análogos & derivados , Monoterpenos Acíclicos , Antranilato Sintase/metabolismo , Descarboxilases de Aminoácido-L-Aromático/metabolismo , Células Cultivadas , Indução Enzimática , Glucose/metabolismo , Hidroxilação , Oxigenases de Função Mista/metabolismo , Plantas Medicinais/metabolismo , Terpenos/metabolismo , Transferases/metabolismo , Triptaminas/metabolismo , Ioimbina/metabolismoRESUMO
An alkaloidal fraction was obtained from Mimosa tenuiflora (Willd.) Poir (tepescohuite) trunk bark. The product contained mainly an indolealkylamine and three minor alkaloids. This fraction inhibited the peristaltic reflex in the guinea-pig isolated ileum in vitro.